Evolent Health Reports Results for Quarter Ended June 30, 2026

What Happened
Evolent Health, Inc. announced its financial results for the quarter ended June 30, 2026 by issuing a press release dated August 6, 2026. The company filed a Form 8-K (Item 2.02) on August 6, 2026 furnishing that press release as Exhibit 99.1. The filing was signed by Jonathan D. Weinberg, General Counsel and Secretary.

Key Details

• Filing date: August 6, 2026.
• Reporting period: quarter ended June 30, 2026.
• Exhibit provided: Press Release (Exhibit 99.1) dated August 6, 2026; cover page included in Inline XBRL (Exhibit 104).
• Disclosure type: results were furnished under Item 2.02 (Results of Operations and Financial Condition); exhibits listed under Item 9.01.

Why It Matters
This 8-K signals Evolent’s quarterly earnings disclosure—key for investors tracking revenue, profit/loss, cash flow and any commentary on business trends or outlook. The press release (Exhibit 99.1) contains the specific financial metrics and management commentary; investors should review that release and look for the company’s subsequent Form 10-Q for audited/expanded financial statements and additional detail.